Following the recent data for hyperbaric oxygen therapy in the treatment of long COVID symptoms, we were delighted to speak with Prof. Shai Efrati (Shamir Medical Center, Be’er Ya’akov, Israel) to discuss the recent study investigating hyperbaric oxygen therapy, and its findings as well as what questions remain unanswered and what future studies are planned.
Questions:
- What is the rationale for investigating hyperbaric oxygen therapy in the treatment of long COVID? (00:29)
- Could you tell us about the recent study investigating hyperbaric oxygen therapy, and its findings? (02:23)
- What questions remain unanswered and what future studies are planned? (05:19)
Disclosures: Shai Efrati is a consultant for AVIV scientific.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Katey Gabrysch.
